Does empagliflozin modulate the autonomic system among patients with type 2 diabetes and coronary artery disease? Insights from the Holter sub-study of the EMPA-Heart CardioLink-6 Randomised Trial
Event:
ESC Congress 2019
Topic:
Clinical
Session:
Arrhythmias, miscellaneous
